Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prevalence and the Pathophysiological Role of Non-Helicobacter Pylori Helicobacter Spp. in Well-defined Gastric Diseases and (Pre-) Malignancies

NCT07770126 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07770126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prevalence and the Pathophysiological Role of Non-Helicobacter Pylori Helicobacter Spp. in Well-defined Gastric Diseases and (Pre-) Malignancies
Lead sponsor
Universiteit Antwerpen
Phase
Observational
Overall status
Recruiting
Start date
February 24, 2025
Completion date
March 31, 2028
Enrollment
150 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atrophic gastritis, dysplasia stomach, functional dyspepsia, gastric cancer (gc), gastritis, gastritis chronic, helicobacter infection, intestinal metaplasia of gastric mucosa, nhph prevalence